EL SEGUNDO, Calif. — Gov. Gavin Newsom announced Thursday that CalRx biosimilar insulin glargine pens will be available to consumers in California beginning Jan. 1, 2026. The launch comes amid the ...
The Supreme Court of Canada has restored an attempted murder conviction in a case involving an apparent attempted murder-suicide with a Toronto nurse, her mother and daughter.
An Ontario trial judge was right to give the jury in a murder trial instructions that did not account for the possibility ...
Getting to grips with rising diabetes rates is arguably one of the most urgent tasks for South Africa's public healthcare system, but the setbacks keep coming. While some communities are facing ...
As part of the settlement, CVS admitted and accepted responsibility for certain conduct alleged by the government, including ...
CVS Pharmacy will pay $37.76 million to resolve allegations that it over-dispensed insulin pens and improperly billed federal health programs over a 10-year period. The settlement resolves claims that ...
CVS Health agreed to pay $37.76 million to settle allegations that it dispensed too many insulin pens to patients and ...
NEW YORK, Dec 2 (Reuters) - CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained improper reimbursements from Medicare, Medicaid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback